Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL COURTIERE - PHARMACIE DE BRETAGNE : revenue, balance sheet and financial ratios

SELARL COURTIERE - PHARMACIE DE BRETAGNE is a French company founded 18 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in BRUZ (35170), this company of category PME shows in 2024 a net income positive of 74 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL COURTIERE - PHARMACIE DE BRETAGNE (SIREN 502811805)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017
Revenue N/C N/C N/C N/C N/C N/C N/C N/C
Net income 74 172 € 35 088 € 148 695 € 122 401 € 147 340 € 119 395 € 136 333 € 120 732 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, SELARL COURTIERE - PHARMACIE DE BRETAGNE generates positive net income of 74 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 121 k€ -> 74 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

74 172 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 45%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 58%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

45.478%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

58.314%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

40.2%

Solvency indicators evolution
SELARL COURTIERE - PHARMACIE DE BRETAGNE

Sector positioning

Debt ratio
45.48 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good

In 2024, the debt ratio of SELARL COURTIERE - PHARMA... (45.48) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
58.31% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good

In 2024, the financial autonomy of SELARL COURTIERE - PHARMA... (58.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 126.98. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

126.978

Liquidity indicators evolution
SELARL COURTIERE - PHARMACIE DE BRETAGNE

Sector positioning

Liquidity ratio
126.98 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Watch -50 pts over 3 years

In 2024, the liquidity ratio of SELARL COURTIERE - PHARMA... (126.98) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Positioning of SELARL COURTIERE - PHARMACIE DE BRETAGNE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELARL COURTIERE - PHARMACIE DE BRETAGNE is estimated at 1 035 495 € (range 721 103€ - 1 549 161€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
721k€ 1035k€ 1549k€
1 035 495 € Range: 721 103€ - 1 549 161€
NAF 5 année 2024

Valuation method used

Net Income Multiple
74 172 € × 14.0x = 1 035 496 €
Range: 721 103€ - 1 549 161€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL COURTIERE - PHARMACIE DE BRETAGNE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL COURTIERE - PHARMACIE DE BRETAGNE

What is the revenue of SELARL COURTIERE - PHARMACIE DE BRETAGNE ?

The revenue of SELARL COURTIERE - PHARMACIE DE BRETAGNE is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL COURTIERE - PHARMACIE DE BRETAGNE profitable?

Yes, SELARL COURTIERE - PHARMACIE DE BRETAGNE generated a net profit of 74 k€ in 2024.

Where is the headquarters of SELARL COURTIERE - PHARMACIE DE BRETAGNE ?

The headquarters of SELARL COURTIERE - PHARMACIE DE BRETAGNE is located in BRUZ (35170), in the department Ille-et-Vilaine.

Where to find the tax return of SELARL COURTIERE - PHARMACIE DE BRETAGNE ?

The tax return of SELARL COURTIERE - PHARMACIE DE BRETAGNE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL COURTIERE - PHARMACIE DE BRETAGNE operate?

SELARL COURTIERE - PHARMACIE DE BRETAGNE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.